83 studies found for:    vaccine adverse reactions | Open Studies
Show Display Options
Rank Status Study
21 Unknown  Immunogenicity and Reactogenicity of a Trivalent MMR (Trivivac) in Healthy Infants
Conditions: Immunogenicity;   Reactogenicity
Intervention: Biological: Trivivac vaccine
22 Unknown  Safety and Immune Response to Adjuvanted A(H1N1)v Influenza Vaccine in HIV-1 Infected and Immunosuppressed Adult Patients
Conditions: HIV-1 Infection;   Cancer;   Immunosuppression
Intervention: Other: serologic testing
23 Recruiting The National Cancer Institute Opens A Randomized, Double-Blind, Phase 2 Trial of GI-6301 (Yeast-Brachyury Vaccine) Versus Placebo in Combination With Standard of Care Definitive Radiotherapy in Locally Advanced, Unresectable, Chordoma
Condition: Chordoma
Interventions: Other: GI-6301 Placebo;   Biological: GI-6301 Vaccine (Yeast- Brachyury);   Radiation: Radiotherapy
24 Unknown  The Effect and Safety of the Seasonal Trivalent Influenza Vaccine in Chronic Kidney Disease Patients Not on Dialysis
Conditions: Immunogenicity and Adverse Drug Effect of Vaccines Influenza;   Chronic Kidney Disease
Intervention: Biological: Seasonal influenza vaccine (AdimFlu-S)
25 Unknown  Safety and Efficacy of Intradermal Trivalent Influenza Vaccination in Institutionalized Older Adults
Condition: Influenza, Human
Interventions: Drug: Intanza;   Drug: Vaxigrip
26 Unknown  Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine,Formulation 2011-2012, in Dialysis Patients
Condition: Influenza
Intervention: Drug: AdimFlu-S
27 Recruiting αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies
Conditions: Malignant Neoplasm of Pancreas Metastatic to Peritoneal Surface;   Malignant Peritoneal Mesothelioma;   Peritoneal Carcinomatosis
Interventions: Biological: DC vaccine;   Drug: Celecoxib;   Drug: Interferon Alfa-2b;   Biological: rintatolimod
28 Not yet recruiting Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of an Adenovirus-based Tuberculosis Vaccine Administered by Aerosol
Condition: Tuberculosis
Intervention: Biological: Ad5Ag85A
29 Unknown  Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination
Conditions: Acute Myeloid Leukemia;   Acute Lymphoblastic Leukemia;   Chronic Myeloid Leukemia;   Non Hodgkin's Lymphoma;   Hodgkin's Disease;   Myelodysplastic Syndrome;   Multiple Myeloma;   Aplastic Anemia
Intervention: Biological: allogeneic donor derived B-lymphocytes
30 Unknown  The Influence of Probiotics on the Immunologic Response to Vaccinations in Infants
Conditions: Immunity;   Measles;   Mumps;   Rubella
Interventions: Dietary Supplement: Probiotics (L.acidophilus and B.lactis);   Dietary Supplement: Cornflor
31 Unknown  Safety Study of Recombinant Listeria Monocytogenes(Lm)Based Vaccine Virus Vaccine to Treat Oropharyngeal Cancer
Condition: HPV-16 +ve Oropharyngeal Carcinoma
Intervention: Biological: ADXS11-001
32 Recruiting Polysaccharide Antibody Response Study
Condition: Specific Polysaccharide Antibody Deficiency
Interventions: Biological: Pneumovax 23 (Sanofi Pasteur MSD);   Biological: Typhim Vi (Sanofi Pasteur MSD)
33 Recruiting An Efficacy And Safety Study Evaluating Tofacitinib With And Without Methotrexate Compared To Adalimumab With Methotrexate
Condition: Rhematoid Arthritis
Interventions: Drug: Tofacitinib with methotrexate;   Drug: Tofacitinib without methotrexate;   Biological: Adalimumab with methotrexate
34 Recruiting Gene Transfer for Severe Combined Immunodeficiency, X-linked (SCID-X1) Using a Self-inactivating (SIN) Gammaretroviral Vector
Condition: Severe Combined Immunodeficiency
Intervention: Biological: Gene transfer
35 Unknown  Modulation of Immune Response by Oral Zinc Supplementation in Chemotherapy for Colon Cancer
Conditions: Adjuvant Chemotherapy;   Colon Cancer;   Immunity
Interventions: Dietary Supplement: zinc;   Other: Placebo
36 Not yet recruiting ID Recombinant Ricin Toxin A-Chain Vaccine RVEc™ — 3-Dose Primary Series With Boost
Condition: Ricin Poisoning
Intervention: Biological: RVEc
37 Not yet recruiting IM Recombinant Ricin Toxin Vaccine (RVEc) — 3-Dose Primary Series With Boost
Condition: Ricin Poisoning
Intervention: Biological: RVEc
38 Recruiting Introducing PrEP Into HIV Combination Prevention - Kenya
Condition: HIV
Intervention: Drug: Truvada
39 Recruiting A Study to Describe the Immunogenicity, Safety, and Tolerability of Neisseria Meningitidis Serogroup B Bivalent Recombinant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Subjects Aged ≥24 Months to <10 Years
Condition: MENINGOCOCCAL INFECTION
Interventions: Biological: Bivalent rLP2086 Vaccine;   Biological: Licensed pediatric hepatits A vaccine;   Other: Normal Saline
40 Recruiting Immunogenicity, Safety and Tolerability of a Neisseria Meningitidis Serogroup B Bivalent Recominant Lipoprotein 2086 Vaccine (Bivalent rLP2086) in Healthy Toddlers.
Condition: Meningococcal B Disease
Interventions: Biological: rLP2086 vaccine;   Biological: Pediatric HAV vaccine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years